Protocol of Diuretics Use in Congestive Therapy in Heart Failure

NCT03892148 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 299

Last updated 2026-01-28

No results posted yet for this study

Summary

The main objective of the study is to determine if a diuretic adaptation protocol in the decompensation of chronic heart failure is more effective but also safer than the current non-protocolized practice.

Conditions

Interventions

DRUG

Furosemide

Protocol for the use of diuretics

DRUG

Hydrochlorothiazide

Protocol for the use of diuretics

Sponsors & Collaborators

  • University Hospital, Grenoble

    collaborator OTHER
  • Hospices Civils de Lyon

    collaborator OTHER
  • Hôpital de la Croix-Rousse

    collaborator OTHER
  • CH Puy en Velay

    collaborator UNKNOWN
  • CH Moulins-Yzeure

    collaborator UNKNOWN
  • CH Riom

    collaborator UNKNOWN
  • Infirmerie Protestante de Lyon

    collaborator OTHER
  • CH Issoire

    collaborator UNKNOWN
  • CH Annecy Genevois

    collaborator OTHER
  • University Hospital, Clermont-Ferrand

    lead OTHER

Principal Investigators

  • Guillaume CLERFOND · University Hospital, Clermont-Ferrand

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-05-17
Primary Completion
2023-01-16
Completion
2023-01-16

Countries

  • France

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03892148 on ClinicalTrials.gov